BMC Cancer Oncology

Metabolic–clinical subtypes predict survival in BCLC-C hepatocellular carcinoma receiving synchronous TACE plus targeted and immunotherapy

Liqing Li, Zhitao Lin, Junbao Wei
Springer Nature · 2026-11-12 · DOI 10.1186/s12885-026-17335-x

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →